Authors: Birkebaek, NH Kristiansen, M Seefeldt, T Degn, J Moller, A Heron, I Andersen, PL Moller, JK Ostergard, L

Citation: Nh. Birkebaek et al., Bordetella pertussis and chronic cough in adults, CLIN INF D, 29(5), 1999, pp. 1239-1242

Authors: Shams, H Heron, I

Citation: H. Shams et I. Heron, Mutual interactions between DTaP-IPV and Haemophilus influenzae type b (Hib)-conjugated vaccines in laboratory animal models, BIOLOGICALS, 27(3), 1999, pp. 227-240

Authors: Heron, I Chen, FM Fusco, J

Citation: I. Heron et al., DTaP vaccines from North American vaccine (NAVA): Composition and criticalparameters, BIOLOGICALS, 27(2), 1999, pp. 91-96

Authors: Richmond, P Goldblatt, D Fusco, PC Fusco, JDS Heron, I Clark, S Borrow, R Michon, F

Citation: P. Richmond et al., Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toroid conjugate vaccine in healthy adults, VACCINE, 18(7-8), 1999, pp. 641-646

Authors: Gyhrs, A Lyngholm, E Larsen, SO Aggerbeck, H Heron, I

Citation: A. Gyhrs et al., Immunogenicity and safety of a tetravalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine, SC J IN DIS, 31(6), 1999, pp. 579-585

Authors: Arciniega, JL Corbel, M Dellepiane, N Dobbelaer, R Griffiths, E Heron, I Ivanoff, B Kreeftenberg, H Mastrantonio, P Meade, B Milstien, J Robertson, S Robinson, A Sato, H Sato, Y Schwanig, M Tiru, M

Citation: Jl. Arciniega et al., WHO guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines (Reprinted from WHO Technical Report Series, No.878, 1998), BIOLOGICALS, 26(3), 1998, pp. 195-204